Compare Danaher Corporation (DHR) vs Synchrony Financial (SYF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Synchrony Financial — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Synchrony Financial trades at $72.8 (market cap $23.99B). The key difference: Danaher Corporation is far larger — about 6.4× Synchrony Financial's market cap, and Synchrony Financial pays the higher dividend (1.84%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Synchrony Financial for 29 Days on average.
| DHR | SYF | |
|---|---|---|
Market Cap | $152.87B | $23.99B |
Volume | 5,228,698 | 3,813,027 |
Sector | Health | Financials |
52-Week High | $242.05 | $88.47 |
52-Week Low | $161.91 | $63.78 |
Typical Hold Time | 69 Days | 29 Days |
Enterprise Value | $175.08B | $24.23B |
Dividend Yield | 0.74% | 1.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
Synchrony Financial (SYF) trades at $72.80, up 1.21% on the day, with a bullish technical signal despite some bearish moving average indicators. The company demonstrates strong fundamentals with a low P/E ratio of 7.56 and robust profitability, including a 23.4% net income margin and 22.23% ROE. Recent earnings have consistently beaten estimates, and positive news includes a partnership with OpenAI and expansion of its CareCredit platform.
The outlook is positive, supported by strong analyst consensus with a $87.58 price target and a 'Moderate Buy' rating. Key opportunities include attractive valuation and strategic partnerships, while risks involve increased investing outflows leading to negative net cash flow in 2026 and potential economic sensitivity affecting credit performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →
